Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia

Hematology/ Oncology and Stem Cell Therapy

Volumn 2, Issue 1, 2009, Pages 285-288

  Singh, Raj K ^a   Tripathi, Anil K ^a   Tripathi, Payal ^a   Singh, Sushma ^a   Singh, Ranjana ^a   Ahmad, Rizwan ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYDROXYUREA; IMATINIB; LIPID HYDROPEROXIDE; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN CARBONYLATION; SPECTROPHOTOMETRY;

EID: 77953660479     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1658-3876(09)50039-8     Document Type: Article

References (30)

1. Kurzrock R, Kantarjian HM, Drucker BJ and Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med. 2003;138:819-830.
2. Wulf Dröge. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95. (Pubitemid 34654215)
3. Das UN. A radical approach to cancer. Med Sci Monit. 2002;8:RA79-RA92.
4. Ray G, Husain SA. Oxidants, antioxidant and carcinogenesis. Ind J Exp Biol. 2002;40:1213-1232.
5. Galli F, Piroddi M, Annetti C, et al. Oxidative stress and reactive oxygen species. Contrib Nephrol. 2005;149:240-260. (Pubitemid 43265021)
6. Singh R, Singh RK, Mahdi AA, et al. Circadian periodicity of plasma lipid peroxide and other antioxidants as putative markers in gyenological malignancies. In Vivo. 2003;17:593-600. (Pubitemid 38165461)
7. Singh R, Singh RK, Mahdi AA, et al. Chronomics of circulating plasma lipid peroxides and antioxidant enzymes and related molecules in cirrhosis of liver. Biomed Pharmacol. 2005;59:S228-S234. (Pubitemid 41586175)
8. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milazani A. Biomarkers of oxidative stress in human disease. Clin Chem. 2006;52:601-623.
9. Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SA. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Research and Treatment. 2000;59:163-170. (Pubitemid 30216139)
10. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. Oxford University Press, USA; 1999:128-161
11. Irshad M, Chaudhuri PS. Oxidant-antioxidant system: role and significance in human body. Ind J Exp Biol. 2002;40:1233-1239. (Pubitemid 35307153)
12. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Rad Biol Med. 1997;22:269-285.
13. Singh V, Ghalaut PS, Kharb S and Singh GP. Plasma concentrations of lipid peroxidation products in children with acute leukemia. Ind J Med Sci. 2001;55:215-217.
14. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milazani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med. 2006;10(2):389-406. (Pubitemid 44870187)
15. Manoharan S, Kolanjiappan K, Suresh K, Panjamutrhy K. Lipid peroxidation and antioxidant status in patients with oral squamous cell carcinoma. Indian J Med Res. 2005;122:529-534. (Pubitemid 43299931)
16. Giacomo CD, Acquaviva R, Lanteri R, et al. Nonproteic antioxidant status in plasma of subjects with colon cancer. Exp Biol Med. 2003;228:525-528. (Pubitemid 37203671)
17. Ghalaut VS, Ghalaut PS, Singh S. Lipid peroxidation in leukemia. J Asso Phys Ind. 1999;47:403-405.
18. Tandon R, Behl D, Khanna R, Khanna HD. A study of oxidative stress in leukemia. J Int Med Ind. 2002;5:173-175.
19. Abd-El-Rahman MAH, Soliman SF, Tolba KA El-Kabbany ZA, Makhlouf MS. Plasma concentrations of lipid peroxidation products in children with acute lymphoblastic leukemia. Clin Chem. 1992;38:594-595.
20. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content of oxidatively modified proteins. Methods Enzymol. 1990;186:464-478.
21. Lowry, OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagents. J Biol Chem. 1951;193:265-275.
22. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421-431. (Pubitemid 20279983)
23. Wolf SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxide. Methods enzymol.1994;233:182- 189. (Pubitemid 24177541)
24. Rossner P, Terry MB, Gammon MD, et al. Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med. 2007;11(5):1138-1148. (Pubitemid 350037055)
25. Morabito F, Cristani M, Saija A, Stelitano C, Callea V, Tomaino A, Minciullo PL, Gangemi S. Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma. Mediators Inflam. 2004;13(5-6):381-383.
26. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H, Ohshima H. Nitrated and oxidized protein in smokers and lung cancer patients. Cancer Res. 2001;61(2):778-784. (Pubitemid 32128646)
27. Popadiuk S, Korzon M, Renke J, Wozniak M. Carbonyl group content on the basis of protein peroxidation analysis with total antioxidant status in blood of children with cancers. Wiad Lek. 1998;51:107-112. Polish.
28. Geetha A, Karthiga S, Surendran G, Jayalakshmi G. Biochemical studies on the level of lipid hydroperoxide and antioxidants in different types of obstructive jaundice. J Lab Med. 2001;2:20-27.
29. Sattler M, Verma S, Shrikhande G, et al. The BCR/ABL tryrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem. 2000;275:24273-24278. (Pubitemid 30626515)
30. Koptyra M, Falinski R, Nowicki M, Stoklosa T, Majsterek I, Nieborowska-Skorska M, Blasiak J, Skorski T. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood. 2006;108(1):319-327. (Pubitemid 43990645)